Literature DB >> 15528728

Porphyromonas uenonis sp. nov., a pathogen for humans distinct from P. asaccharolytica and P. endodontalis.

Sydney M Finegold1, Marja-Liisa Vaisanen, Merja Rautio, Erkki Eerola, Paula Summanen, Denise Molitoris, Yuli Song, Chengxu Liu, Hannele Jousimies-Somer.   

Abstract

Three Porphyromonas species (Porphyromonas asaccharolytica, P. endodontalis, and the novel species that is the subject of the present report, P. uenonis) are very much alike in terms of biochemical characteristics, such as enzyme profiles and cellular fatty acid contents. P. asaccharolytica is distinguished from the other two species by virtue of production of alpha-fucosidase and glyoxylic acid positivity. The novel species is difficult to differentiate from P. endodontalis phenotypically and was designated a P. endodontalis-like organism for some time. However, P. endodontalis is recovered almost exclusively from oral sources and also grows poorly on Biolog Universal Agar, both characteristics that are in contrast to those of the other two organisms. Furthermore, P. uenonis is glycerol positive in the Biolog AN Microplate system. Both P. asaccharolytica and P. uenonis are positive by 13 other tests in the Biolog system, whereas P. endodontalis is negative by all of these tests. P. asaccharolytica grew well in both solid and liquid media without supplementation with 5% horse serum, whereas the other two species grew poorly without supplementation. Sequencing of 16S rRNA revealed about 10% divergence between the novel species and P. endodontalis but less than 2% sequence difference between the novel species and P. asaccharolytica. Subsequent DNA-DNA hybridization studies documented that the novel organism was indeed distinct from P. asaccharolytica. We propose the name Porphyromonas uenonis for the novel species. We have recovered P. uenonis from four clinical infections in adults, all likely of intestinal origin, and from the feces of six children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528728      PMCID: PMC525138          DOI: 10.1128/JCM.42.11.5298-5301.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Enzymatic profiles of Prevotella, Porphyromonas, and Bacteroides species obtained with the API ZYM system and Rosco diagnostic tablets.

Authors:  B Durmaz; H R Jousimies-Somer; S M Finegold
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

2.  GenBank.

Authors:  D A Benson; M S Boguski; D J Lipman; J Ostell
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

3.  The quantitative measurement of DNA hybridization from renaturation rates.

Authors:  J De Ley; H Cattoir; A Reynaerts
Journal:  Eur J Biochem       Date:  1970-01

Review 4.  Update on the taxonomy and the clinical and laboratory characteristics of pigmented anaerobic gram-negative rods.

Authors:  H R Jousimies-Somer
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

5.  Further characterization of Bacteroides endodontalis, an asaccharolytic black-pigmented Bacteroides species from the oral S cavity.

Authors:  A J van Winkelhoff; T J van Steenbergen; N Kippuw; J De Graaff
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

6.  Porphyromonas gingivicanis sp. nov. and Porphyromonas crevioricanis sp. nov., isolated from beagles.

Authors:  M Hirasawa; K Takada
Journal:  Int J Syst Bacteriol       Date:  1994-10
  6 in total
  8 in total

1.  Sydney M. Finegold.

Authors: 
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

2.  Porphyromonas somerae sp. nov., a pathogen isolated from humans and distinct from porphyromonas levii.

Authors:  Paula H Summanen; Bengül Durmaz; Marja-Liisa Väisänen; Chengxu Liu; Denise Molitoris; Erkki Eerola; Ilkka M Helander; Sydney M Finegold
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Asp- and Glu-specific novel dipeptidyl peptidase 11 of Porphyromonas gingivalis ensures utilization of proteinaceous energy sources.

Authors:  Yuko Ohara-Nemoto; Yu Shimoyama; Shigenobu Kimura; Asako Kon; Hiroshi Haraga; Toshio Ono; Takayuki K Nemoto
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

4.  Solobacterium moorei bacteremia: identification, antimicrobial susceptibility, and clinical characteristics.

Authors:  Rune Micha Pedersen; Hanne Marie Holt; Ulrik Stenz Justesen
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

5.  Vaginal and oral microbes, host genotype and preterm birth.

Authors:  Usha Srinivasan; Dawn Misra; Mary L Marazita; Betsy Foxman
Journal:  Med Hypotheses       Date:  2009-12       Impact factor: 1.538

6.  Characterization of Slackia exigua isolated from human wound infections, including abscesses of intestinal origin.

Authors:  Keun-Sung Kim; Marie-Claire Rowlinson; Robert Bennion; Chengxu Liu; David Talan; Paula Summanen; Sydney M Finegold
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

7.  Comparative Genomics of the Genus Porphyromonas Identifies Adaptations for Heme Synthesis within the Prevalent Canine Oral Species Porphyromonas cangingivalis.

Authors:  Ciaran O'Flynn; Oliver Deusch; Aaron E Darling; Jonathan A Eisen; Corrin Wallis; Ian J Davis; Stephen J Harris
Journal:  Genome Biol Evol       Date:  2015-11-13       Impact factor: 3.416

8.  Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX.

Authors:  Jing Li; Jingtao Li; Na Lyu; Yue Ma; Fei Liu; Yuqing Feng; Li Yao; Zhiyong Hou; Xiaofeng Song; Hongchuan Zhao; Xiaoya Li; Yingdian Wang; Cheng Xiao; Baoli Zhu
Journal:  Ther Adv Chronic Dis       Date:  2020-02-26       Impact factor: 5.091

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.